Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Johnson & Johnson Slammed with $8 Billion Risperdal Verdict

Johnson & Johnson was ordered to pay $8 billion in punitive damages to a Maryland man yesterday, after a Philadelphia jury found that its Janssen Pharmaceuticals subsidiary intentionally downplayed the potential for Risperdal to cause gynecomastia in boys. According to … Continue reading

New York Child Victims Act: Former Patients Allege Abuse by Long Island Pediatrician

Dozens of women alleging abuse at the hands of a once-prominent Long Island pediatrician are finally taking their former doctor to court, thanks to the New York Child Victims Act. Parent’s Rarely Questioned Pediatrician’s Motives According to The New York … Continue reading

Status of Bard Hernia Mesh Lawsuits Discussed at October Conference

The federal court overseeing hernia mesh lawsuits involving various polypropylene implants marketed by C.R. Bard, Inc. and its Davol, Inc. subsidiary convened the litigation’s most recent Status Conference on October 1st. 400 New Hernia Mesh Filings Per Month Nearly 4,070 … Continue reading

Little Rock, Arkansas Hotel Aided Sex Trafficking, Lawsuit Claims

A hotel in Little Rock, Arkansas allegedly enabled sex trafficking, going so far as to allow pimps exclusive access to an entire floor of the building. Sex Trafficking Lawsuit Allegations According to a sex trafficking lawsuit filed last week in … Continue reading

Missouri Glyphosate Trial Delayed, as Roundup Settlement Talks Continue

A Missouri state court judge has agreed to delay an upcoming Roundup lawsuit trial, the latest to be postponed as Bayer attempts to negotiate a settlement with thousands of plaintiffs who claim glyphosate caused cancer. Bayer Defending Over 18,000 Roundup … Continue reading

3M Military Earplugs Court Issues 5th Case Management Order

Thousands of lawsuits involving the 3M Company’s Combat Arms Earplugs, Version 2, continue to move forward in the U.S. District Court, Northern District of Florida. 3M Military Earplugs Discovery and Depositions Progressing The Court issued the litigation’s fifth Case Management … Continue reading

Plaintiffs Request Centralization for Allergan Breast Implant Lawsuits

Plaintiffs suing over Allergan Inc.’s recently recalled Biocell textured breast implants are seeking to have their claims centralized in a single federal court. According to a motion filed with the U.S. Judicial Panel on Multidistrict Litigation (JPML) on October 3rd, … Continue reading

Pennsylvania Senate Considers Extending Child Sex Abuse Lawsuit Deadlines

The Pennsylvania State Senate is considering several proposals that would significantly extend the deadlines for filing civil lawsuits against child sexual abusers, as well as any institutions that protected wrongdoers and enabled their predatory behavior. What’s Been Proposed in Pennsylvania … Continue reading

FDA Acknowledges Unacceptable Levels of NDMA in Zantac and Ranitidine

More than two weeks after the U.S. Food & Drug Administration (FDA) warned of the presence of a cancer-causing chemical in Zantac and other ranitidine-containing antacids, the agency acknowledge that “early, limited testing” did turn up unacceptably high levels in … Continue reading

Xeljanz, Other New RA Treatments Might Not be Worth Hefty Price Tag

A new report suggests Xeljanz and other new treatments for rheumatoid arthritis (RA) aren’t as cost effective as their older competitors. Xeljanz Only Marginally Better than Humira The analysis, which was conducted by the Institute for Clinical and Economic Review … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content